Phase II Trial of Neoadjuvant Cisplatin, Gemcitabine and Sunitinib Malate Followed by Radical Cystectomy for Transitional Cell Carcinoma (TCC) of the Bladder

For full description, see www.clinicaltrials.gov.

Abstracts/Posters/Presentations:

• S. Lerner, N.M. Hahn, T. Powles, T. A. Gardner, L. Cheng, J.S. Green, D. M. Berney, D. Taber, J. Hudak, J. Landgraf, S. Shen, G. Sonpavde. A Phase II Trial of Neoadjuvant Cisplatin (C), Gemcitabine (G), and Sunitinib (S) in Muscle-Invasive Urothelial Carcinoma (miUC): Results from Hoosier Oncology Group GU07-123 Trial. Accepted as abstract at the ASCO Annual Meeting, June 4-8 2011, Chicago, IL. J Clin Oncol 29: 2011 (suppl; abstr e15173). See abstract.